Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Retinopathy of Prematurity > Number of laser shots applied affects myopic status in retinopathy of prematurity
  • Retinopathy of Prematurity

Number of laser shots applied affects myopic status in retinopathy of prematurity

Ophthalmology 360

Axial length (AL), corneal refraction (CR), and crystalline lens power (CLP) are related to the degree of myopia in laser-treated retinopathy of prematurity (ROP) eyes, according to a study, which also found the number of laser shots applied also affects myopic status.

The study included 17 infants with ROP who received laser treatment. The researchers performed retinoscopic refraction testing to calculate spherical equivalent (SE) and analyzed the relationship between SE and variables such as the number of laser shots applied. The study also included an age-matched control group without ROP for comparison of ocular structural parameters.

In the group with ROP, SE was significantly more myopic than the control group, but there was no statistical difference in AL between the groups.

In the ROP group, SE exhibited a correlation with AL, CR, and CLP. Among these 3 factors, a significant correlation (P = 0.003) was found between CLP and the number of laser shots applied, whereas no correlations were observed between the number of laser shots and AL or CR (P = 0.15 and 0.10, respectively). A similar trend was observed in the analysis of the interocular difference between the right and left eyes of each child.

Reference
Asano S, Inoue T, Kure K, et al. Investigating the factors affecting myopia in retinopathy of prematurity after laser treatment. Int J Retina Vitreous. 2023;9(1):27. doi: 10.1186/s40942-023-00456-x. PMID: 37046346; PMCID: PMC10091611.

Share

Related Content

  • Retinopathy of Prematurity

Quiz: ROP Pharmacologic Strategies

  • Retinopathy of Prematurity

Three-year FIREFLEYE outcomes reported for aflibercept vs laser in ROP

1 Min Read
  • Retinopathy of Prematurity

Study highlights link between obesity indicators and risk of retinopathy

  • Retinopathy of Prematurity

Declining trends in retinopathy of prematurity screening eligibility among U.S. infants

  • Anterior Segment

Shorter axial length and steeper corneas found in preterm children with ROP

  • Retina

Global survey reveals trends in treatment for retinopathy of prematurity

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon